Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer

NCT01388790 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Cetuximab
DRUG: Cisplatin
DRUG: S-1

Sponsor

Merck KGaA, Darmstadt, Germany